Irinotecan‐based regimens vs irinotecan
Tumour response · people with metastatic CRC
Irinotecan‐based regimens leads to higher overall tumour response compared with irinotecan (high certainty).
1 finding from 1 review
- Second‐line systemic therapy for metastatic colorectal cancer 2017 · Cochrane Headline outcomes onlyRR 2.87 [2.1, 3.93]6 studies · 2577 participantsHigh